SwePub
Sök i SwePub databas

  Utökad sökning

Träfflista för sökning "WFRF:(Holmberg M) srt2:(2020-2024)"

Sökning: WFRF:(Holmberg M) > (2020-2024)

  • Resultat 1-10 av 130
Sortera/gruppera träfflistan
   
NumreringReferensOmslagsbildHitta
1.
  •  
2.
  •  
3.
  •  
4.
  •  
5.
  •  
6.
  •  
7.
  • Bedoya-Reina, O. C., et al. (författare)
  • Single-nuclei transcriptomes from human adrenal gland reveal distinct cellular identities of low and high-risk neuroblastoma tumors
  • 2021
  • Ingår i: Nature Communications. - : Springer Science and Business Media LLC. - 2041-1723. ; 12:1
  • Tidskriftsartikel (refereegranskat)abstract
    • Childhood neuroblastoma has a remarkable variability in outcome. Age at diagnosis is one of the most important prognostic factors, with children less than 1 year old having favorable outcomes. Here we study single-cell and single-nuclei transcriptomes of neuroblastoma with different clinical risk groups and stages, including healthy adrenal gland. We compare tumor cell populations with embryonic mouse sympatho-adrenal derivatives, and post-natal human adrenal gland. We provide evidence that low and high-risk neuroblastoma have different cell identities, representing two disease entities. Low-risk neuroblastoma presents a transcriptome that resembles sympatho- and chromaffin cells, whereas malignant cells enriched in high-risk neuroblastoma resembles a subtype of TRKB+ cholinergic progenitor population identified in human post-natal gland. Analyses of these populations reveal different gene expression programs for worst and better survival in correlation with age at diagnosis. Our findings reveal two cellular identities and a composition of human neuroblastoma tumors reflecting clinical heterogeneity and outcome. Childhood neuroblastoma can be separated into high and low risk groups, with prognosis depending on age at diagnosis. Here, the authors show that low and high risk neuroblastoma tumours are composed of different cell types with different malignancy potential.
  •  
8.
  • Borgenvik, Anna, 1987-, et al. (författare)
  • Dormant SOX9-Positive Cells Facilitate MYC-Driven Recurrence of Medulloblastoma
  • 2022
  • Ingår i: Cancer Research. - : AMER ASSOC CANCER RESEARCH. - 0008-5472 .- 1538-7445. ; 82:24, s. 4586-4603
  • Tidskriftsartikel (refereegranskat)abstract
    • Relapse is the leading cause of death in patients with medulloblas-toma, the most common malignant pediatric brain tumor. A better understanding of the mechanisms underlying recurrence could lead to more effective therapies for targeting tumor relapses. Here, we observed that SOX9, a transcription factor and stem cell/glial fate marker, is limited to rare, quiescent cells in high-risk medulloblastoma with MYC amplification. In paired primary-recurrent patient samples, SOX9-positive cells accumulated in medulloblastoma relapses. SOX9 expression anti-correlated with MYC expression in murine and human medulloblastoma cells. However, SOX9-positive cells were plastic and could give rise to a MYC high state. To follow relapse at the single-cell level, an inducible dual Tet model of medulloblastoma was developed, in which MYC expression was redirected in vivo from treatment-sensitive bulk cells to dormant SOX9-positive cells using doxycycline treatment. SOX9 was essential for relapse initiation and depended on suppression of MYC activity to promote therapy resistance, epithelial-mesenchymal transition, and immune escape. p53 and DNA repair pathways were downregulated in recurrent tumors, whereas MGMT was upregulated. Recurrent tumor cells were found to be sensitive to treatment with an MGMT inhibitor and doxorubicin. These findings suggest that recurrence-specific targeting coupled with DNA repair inhibition comprises a potential therapeutic strategy in patients affected by medulloblastoma relapse.Significance: SOX9 facilitates therapy escape and recurrence in medulloblastoma via temporal inhibition of MYC/MYCN genes, revealing a strategy to specifically target SOX9-positive cells to prevent tumor relapse.
  •  
9.
  •  
10.
  •  
Skapa referenser, mejla, bekava och länka
  • Resultat 1-10 av 130
Typ av publikation
tidskriftsartikel (113)
konferensbidrag (10)
forskningsöversikt (5)
rapport (1)
annan publikation (1)
Typ av innehåll
refereegranskat (107)
övrigt vetenskapligt/konstnärligt (23)
Författare/redaktör
Sparrelid, E (18)
Ghorbani, P (16)
Holmberg, J (9)
Holmberg, Erik, 1951 (9)
Holmberg, L (7)
Lagergren, J (6)
visa fler...
Larsson, P (6)
Holmberg, E. (6)
Santoni, G (6)
Sakamoto, T. (6)
Holmberg, Hans-Chris ... (6)
Skrifvars, MB (6)
Castrén, M (6)
Swartling, O (6)
Holmberg, D. (6)
Roehr, CC (6)
Berg, KM (6)
Bray, JE (6)
Liley, HG (6)
Greif, R (6)
Carlson, JN (6)
Morley, PT (6)
Drennan, IR (6)
Weiner, GM (6)
Cheng, A (6)
Andersen, LW (6)
Berry, DC (6)
Bhanji, F (6)
Borra, V (6)
Breckwoldt, J (6)
Cassan, P (6)
Chang, WT (6)
Charlton, NP (6)
Chung, SP (6)
Considine, J (6)
Costa-Nobre, DT (6)
Couper, K (6)
Dainty, KN (6)
Davis, PG (6)
Deakin, CD (6)
Douma, MJ (6)
El-Naggar, W (6)
Fabres, JG (6)
Fawke, J (6)
Foglia, EE (6)
Folke, F (6)
Gilfoyle, E (6)
Goolsby, CA (6)
Guinsburg, R (6)
Hirsch, KG (6)
visa färre...
Lärosäte
Karolinska Institutet (85)
Göteborgs universitet (31)
Uppsala universitet (20)
Lunds universitet (12)
Linköpings universitet (9)
Kungliga Tekniska Högskolan (7)
visa fler...
Örebro universitet (7)
Umeå universitet (6)
Mittuniversitetet (6)
Luleå tekniska universitet (4)
Malmö universitet (3)
Stockholms universitet (2)
Chalmers tekniska högskola (2)
Sveriges Lantbruksuniversitet (1)
visa färre...
Språk
Engelska (129)
Svenska (1)
Forskningsämne (UKÄ/SCB)
Medicin och hälsovetenskap (50)
Naturvetenskap (13)
Teknik (4)
Samhällsvetenskap (2)

År

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy